Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001486180-25-000006
Filing Date
2025-10-24
Accepted
2025-10-24 11:50:41
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D  
1 primary_doc.xml SCHEDULE 13D 4839
  Complete submission text file 0001486180-25-000006.txt   6866
Mailing Address 9713 KEY WEST AVENUE, SUITE 400 ROCKVILLE MD 20850
Business Address 9713 KEY WEST AVENUE, SUITE 400 ROCKVILLE MD 20850 301-517-5556
MAXCYTE, INC. (Subject) CIK: 0001287098 (see all company filings)

EIN.: 522210438 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D | Act: 34 | File No.: 005-92738 | Film No.: 251415204
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)

Mailing Address 30 COLEMAN STREET LONDON X0 EC2R 5AL
Business Address 30 COLEMAN STREET LONDON X0 EC2R 5AL 44 20 3327 5100
RIVER GLOBAL INVESTORS LLP (Filed by) CIK: 0001486180 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 0331
Type: SCHEDULE 13D